ARCHIVES

NCI Funding Notice.

This article is from The Cancer Letter archive.

Vol. 29 No. 27 | July 4, 2003

Download PDF Visit The Full Archive

Related Articles

FDA Advisors Okay NCI Toxicology Proposals, Write New Clinical Guidelines, Approve AIN DA

October 19, 1979

New Drug for Lymphoma Enters Phase II Trial

May 28, 2004

Cancer Mortality Increase Of 5.2% Now 28% Or Less

January 30, 1976

RFA Available: Chemoprevention Trials

August 5, 1994

PD-1 Checkpoint Inhibitor Opdivo First to Demonstrate Survival Benefit in Phase III

November 28, 2014

RFPS, RFAs Available

September 23, 1994